FDAnews
www.fdanews.com/articles/84684-kyorin-licenses-immunosuppressant-drug-to-novartis

KYORIN LICENSES IMMUNOSUPPRESSANT DRUG TO NOVARTIS

February 20, 2006

Japan's Kyorin Pharmaceutical Co. said on Thursday it had granted a global license to Novartis AG to develop and market its immunosuppressant drug KRP-203, in an effort to speed up the launch of the drug. Under the agreement, Novartis will have an exclusive license to develop and sell the drug worldwide for use in treating organ transplant patients. The drug is still at the pre-clinical stage in Japan.
The Washington Post